Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7742)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 10, 2017 (publication date) through May 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shah K, Curtin BF, Chu C, Hwang D, Flasar MH, von Rosenvinge E. Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia. World J Clin Oncol 2017; 8(5): 398-404 [PMID: 29067276 DOI: 10.5306/wjco.v8.i5.398] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i5/398.htm |
| Number | Citing Articles |
| 1 |
Jianbiao Zhou, Wee-Joo Chng. Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies. World Journal of Clinical Oncology 2018; 9(5): 90-97 doi: 10.5306/wjco.v9.i5.90
|
| 2 |
Aaron C Miller, Alan T Arakkal, Daniel K Sewell, Alberto M Segre, Joseph Tholany, Philip M Polgreen. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study. Open Forum Infectious Diseases 2023; 10(8) doi: 10.1093/ofid/ofad413
|
| 3 |
Olivier Ballo, Eva-Maria Kreisel, Fagr Eladly, Uta Brunnberg, Jan Stratmann, Peter Hunyady, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Björn Steffen, Joerg J. Vehreschild, Maria J. G. T. Vehreschild, Fabian Finkelmeier, Hubert Serve, Christian H. Brandts. Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy. Annals of Hematology 2020; 99(11): 2547 doi: 10.1007/s00277-020-04274-1
|
| 4 |
Yuan-Pin Hung, Chin-Shiang Tsai, Bo-Yang Tsai, Pei-Jane Tsai, Yuan-Ti Lee, Jen-Chieh Lee, Hsiu-Chuan Liu, Po-Ren Hsueh, Ching-Chi Lee, Wen-Chien Ko. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. Journal of Microbiology, Immunology and Infection 2021; 54(6): 1101 doi: 10.1016/j.jmii.2021.02.002
|
| 5 |
Hamzah Abu-Sbeih, Kati Choi, Cynthia N. Tran, Xuemei Wang, Phillip Lum, Gladis Shuttlesworth, John R. Stroehlein, Pablo C. Okhuysen, Yinghong Wang. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. European Journal of Gastroenterology & Hepatology 2019; 31(1): 128 doi: 10.1097/MEG.0000000000001288
|
| 6 |
Maria Cecília Freire de Melo, Thuanny Silva de Macedo, Julianelly Alves Biserra, Karina Luz Cavalcanti Rodrigues, Mônica Cruz, Aurora Karla de Lacerda Vidal. The use of antimicrobial photodynamic therapy in oral injuries of a pediatric patient with myelodysplastic syndrome: case report. Special Care in Dentistry 2018; 38(2): 95 doi: 10.1111/scd.12275
|
| 7 |
Clyde D. Ford, Bert K. Lopansri, Brandon J. Webb, Jana Coombs, Launce Gouw, Julie Asch, Daanish Hoda. Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. American Journal of Infection Control 2019; 47(4): 394 doi: 10.1016/j.ajic.2018.09.027
|
| 8 |
Christopher C. Battaglia, Kaye Hale. Hospital-Acquired Infections in Critically Ill Patients With Cancer. Journal of Intensive Care Medicine 2019; 34(7): 523 doi: 10.1177/0885066618788019
|
| 9 |
Abdulrahman Alamri, AlHanoof Bin Abbas, Ekram Al Hassan, Yasser Almogbel. Development of a Prediction Model to Identify the Risk of Clostridioides difficile Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics. Pharmacy 2024; 12(1): 37 doi: 10.3390/pharmacy12010037
|